Intelligent drug-delivery devices based on micro- and nano-technologies

Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, 500 Technology Square, NE47-525, Cambridge, MA 02139, USA.
Therapeutic delivery 01/2013; 4(1):77-94. DOI: 10.4155/tde.12.139
Source: PubMed


This review focuses on the current drug-delivery modalities in R&D, as well as commercially available. Intelligent drug-delivery systems are described as novel technological innovations and clinical approaches to improve conventional treatments. These systems differ in methodology of therapeutic administration, intricacy, materials and patient compliance to address numerous clinical conditions that require various pharmacological therapies. These systems have been primarily described as active and passive microelectrical mechanical system devices, injectors and nanoparticle-based therapies, optimized to tailor specific pharmacokinetic profiles. The most critical considerations for the design of these intelligent delivery systems include the controlled release, target specificity, on-demand dosage adjustment, mass transfer and stability of the pharmacological agents. Drug-delivery systems continue to be developed and enhanced to provide better and more sophisticated treatments, promising an improvement in quality of life and extension of life expectancy.